Latest News

FDA Approves Donanemab for Early Symptomatic Alzheimer Disease: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves Donanemab for Early Symptomatic Alzheimer Disease: Daily Dose

July 10th 2024

Your daily dose of the clinical news you may have missed.

©Lilly's Donanemab Approved by FDA for Treatment of Early Symptomatic AD / image credit fda approval stamp: waldenmarus/stock.adobe.com
Lilly's Donanemab Approved by FDA for Treatment of Early Symptomatic AD

July 2nd 2024

Adolescent Obesity Linked to Higher Stroke Risk in Women: Daily Dose / image credit: ©New Africa/AdobeStock
Adolescent Obesity Linked to Higher Stroke Risk in Women: Daily Dose

June 14th 2024

Women with Overweight/Obesity as Teens, Young Adults Face Higher Risk of Cerebrovascular Disease Later in Life / Image credit: ©Rytis/AdobeStock
Women with Overweight/Obesity as Teens, Young Adults Face Higher Risk of Cerebrovascular Disease Later in Life

June 11th 2024

Eisai Files sBLA for Lecanemab-irmb Maintenance Dose, Reports Delay on SC Formulation / image credit Alzheimer disease concept: ©Zerbor/stock.adobe.com
UPDATE 6-11-2024: Eisai Files sBLA for Lecanemab-irmb Maintenance Dosing

June 11th 2024

Latest CME Events & Activities

Facing the Challenges of Implementing Palliative Care

View More

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, ...

September 15, 2024

Register Now!

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

October 16, 2024

Register Now!

Mastering MS: Translating Evidence into Optimal Management Plans

View More

Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care

View More

Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Burst CME: Optimizing Therapy in Parkinson’s Disease

View More

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of the Complement Pathway in Neurological Disorders

View More

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

View More

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

More News

© 2024 MJH Life Sciences

All rights reserved.